In summary, our data suggest that defective action of adiponectin, as a result of the reduction both of adiponectin serum levels and an associated reduction in adiponectin receptors in theca cells, contributes significantly to the exacerbation of androgen excess in overweight or obese women with PCOS. The gene discussed is ADIPOQ; the disease is polycystic ovary syndrome.